Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1997 3
1998 2
1999 3
2000 8
2001 4
2002 3
2003 2
2004 1
2005 2
2006 1
2007 3
2008 7
2009 5
2010 3
2011 12
2012 15
2013 17
2014 14
2015 17
2016 24
2017 18
2018 24
2019 19
2020 20
2021 17
2022 14
2023 7
2024 8
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk, et al. Lancet. 2023 Apr 15;401(10384):1277-1292. doi: 10.1016/S0140-6736(23)00285-4. Lancet. 2023. PMID: 37061269 Free PMC article.
Palliative sedation for intolerable suffering.
Maltoni M, Scarpi E, Nanni O. Maltoni M, et al. Among authors: scarpi e. Curr Opin Oncol. 2014 Jul;26(4):389-94. doi: 10.1097/CCO.0000000000000097. Curr Opin Oncol. 2014. PMID: 24825017 Review.
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.
Conteduca V, Scarpi E, Rossi A, Ferroni F, Gurioli G, Bleve S, Gianni C, Schepisi G, Brighi N, Lolli C, Cursano MC, Virga A, Casadei C, Altavilla A, Farolfi A, Ulivi P, Barone D, Matteucci F, De Giorgi U. Conteduca V, et al. Among authors: scarpi e. Oncologist. 2025 May 8;30(5):oyaf107. doi: 10.1093/oncolo/oyaf107. Oncologist. 2025. PMID: 40377440 Free PMC article.
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
Giunta EF, Caroli P, Scarpi E, Altavilla A, Rossetti V, Marini I, Celli M, Casadei C, Lolli C, Schepisi G, Bleve S, Brighi N, Cursano MC, Paganelli G, Matteucci F, De Giorgi U. Giunta EF, et al. Among authors: scarpi e. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):326-334. doi: 10.1007/s00259-024-06887-4. Epub 2024 Aug 29. Eur J Nucl Med Mol Imaging. 2024. PMID: 39207484 Free PMC article.
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial.
Bulgarelli J, Piccinini C, Scarpi E, Gentili G, Renzi L, Carloni S, Limarzi F, Pancisi E, Granato AM, Petrini M, De Rosa F, Guidoboni M, Fanelli D, Tumedei MM, Tazzari M, Baravelli S, Bronico I, Cortesi P, Pignatta S, Capelli L, Ancarani V, Foschi G, Turci L, Tauceri F, Framarini M, Ridolfi L. Bulgarelli J, et al. Among authors: scarpi e. J Transl Med. 2025 Apr 18;23(1):455. doi: 10.1186/s12967-025-06403-8. J Transl Med. 2025. PMID: 40251644 Free PMC article. Clinical Trial.
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants.
Palleschi M, Virga A, Scarpi E, Fonzi E, Musolino A, Merloni F, Sarti S, Danesi R, Ravegnani M, Casadei C, Sirico M, Gianni C, Maltoni R, Bravaccini S, Calistri D, Arcangeli V, Zampiga V, Cangini I, Bandini E, Mannozzi F, Falcini F, Martinelli G, De Giorgi U, Ulivi P, Tedaldi G. Palleschi M, et al. Among authors: scarpi e. Oncologist. 2025 May 8;30(5):oyaf052. doi: 10.1093/oncolo/oyaf052. Oncologist. 2025. PMID: 40338220 Free PMC article.
253 results